Project Grant RF1NS142335
Award Date
6/1/25
Completion Date
5/31/27
Dollars Obligated
$1.5M
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Rensselaer, NY 12144, USA
Similar Awards
This federal Project Grant award, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports the development and validation of Synapticure Inc.'s novel 3D in vitro "Cortical Brain Spheroids" (CBS) platform for modeling genetic and sporadic subtypes of Frontotemporal Dementia (FTD). The $1,253,527 award, with an ultimate completion date of April 30,...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders federal grant program (CFDA 93.853), is funding the development and optimization of a new animal model for amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The award aims to demonstrate a progressive ALS/FTD-like phenotype using aged mouse cohorts and validate the animal findings through...
The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, awarded a $1,138,538 Project Grant (CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders) to Mayo Clinic Jacksonville, a nonprofit healthcare organization, to conduct research on the molecular mechanisms and therapeutic interventions related to frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The research aims to explore the...
This three-year, $5.782 million project grant from the National Institute on Aging, part of the Department of Health and Human Services, will support research into single-cell characterization of frontotemporal lobar degeneration caused by mutations in the progranulin gene. The University of California, San Francisco will map the transcriptome and gene regulatory networks that define glial pathology and neuronal vulnerability in the frontal cortex and thalamus of progranulin-deficient...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, provides $427,625.00 to support research on using directly converted neurons as a novel cellular model for amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The award will enable The Washington University in St. Louis to investigate neurodegenerative...
This $1,076,760 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to the Vlaams Instituut Voor Biotechnologie (VIB) in Belgium will support research to develop a humanized mouse model for frontotemporal lobar degeneration (FTLD) with TDP-43 pathology. The researchers will use the novel MIGRATE protocol to transplant patient-derived GRN-deficient microglia into the brains of human TMEM106B overexpressing mice, and then characterize the resulting...
The National Institute on Aging (NIA) awarded a $1,931,965 Project Grant (CFDA 93.866 - Aging Research) to Regenerative Research Foundation to develop and validate a novel human induced pluripotent stem cell (iPSC) model that incorporates cerebrovascular interactions for studying Alzheimer's disease-related dementias (ADRD). The project aims to generate a 3D human cell model that integrates cerebral cortical neurons, glia, vascular endothelial cells, pericytes, and microglia to improve the...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will provide $274,750 to Purdue University to develop a human-mouse chimeric brain model for studying tau pathology in human neurons in vivo. The objective is to create a translational model that can recapitulate human tau pathology observed in Alzheimer's disease, without introducing...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $2,001,864 to Harvard University to investigate the subcellular mechanisms underlying the selective vulnerability of specific neuron subtypes in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The researchers will quantitatively study the localization of RNA, proteins, and translational regulation in the synapses and soma of vulnerable corticospinal neurons (CSN) and...
The National Institutes of Health (NIH), through the National Institute on Aging (CFDA 93.866 Aging Research program), awarded a $803,111 Project Grant to The Trustees of the University of Pennsylvania. The grant, effective from December 15, 2024 to November 30, 2029, will support a comprehensive study to model and contrast the microscopic, mesoscopic and macroscopic regional progression of neuroinflammation, abnormal iron accumulation and neurodegeneration in human brain tissue from patients...